News for Philadelphia: Major Philly IPO, Big Acquisition & Interesting MedTech Investment Deal and News.

Major Philly IPO
Spark Therapeutics, a Philadelphia-based developer of one-time gene therapy products, raised $161 million in its IPO. The company priced 7 million shares at $23 per share, compared to its upwardly-revised plans to offer 6.5 million shares at between $19 and $21 per share. The company’s initial market cap is approximately $540 million. It will trade on the Nasdaq under ticker symbol ONCE, while J.P. Morgan and Credit Suisse served as co-lead underwriters. Shareholders include Sofinnova Ventures (11.45% pre-IPO stake), Baker Brothers (7.63%), Brookside, Deerfield Management, Rock Springs Capital, T. Rowe Price, Wellington Management, and The Children’s Hospital of Philadelphia.

Big Acquisition
Cerner Corp (Nasdaq: CERB) has completed its previously-announced $1.3 billion acquisition of Siemens Health Services from Siemens AG.

Exciting Philly MedTech Deal
Aspire Bariatrics, a King of Prussia, Penn.-based developer of a reversible minimally-invasive weight loss device for obesity, has secured $12 million in venture debt funding from Hercules Technology Growth Capital.

Interesting MedTech Investment News
I think this is a first for First Round in the medtech sector:
Click here to read the full press details.

©2020 PACT All Rights Reserved